Key result
Repeated genomic sequencing complements traditional one-drug-fits-all medicine to deliver individualized care.
Design
Editorial
Authors
Loading...
May support genomic sequencing for tailored therapies in select cases; leaves open validation in prospective trials.
Kiley et al. (2014) conducted an editorial in Chronic Lung Diseases. Individualized care and genomic sequencing vs. Traditional one-drug-fits-all approach was evaluated. Individualized care using repeated genomic sequencing offers a complementary approach to traditional one-drug-fits-all scientific principles in medicine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: